Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 80351-80400 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT05488548
Dual BET and CBP/p300 Inhibitor in Patients With Targeted Advanced Solid Tumors and Hematological Malignancies
PHASE1Recruiting
75 participants
Started: Dec 21, 2022 · Completed: May 31, 2025
4 conditions1 sponsor6 locations
NCT05633810
COLchicine and Non-enteric Coated Aspirin in the Cardiovascular Outcomes Trial of Patients With Type 2 Diabetes
PHASE3Recruiting
10,000 participants
Started: Dec 21, 2022 · Completed: Dec 31, 2027
2 conditions1 sponsor1 location
NCT06806579
Atezolizumab-bevacizumab and Other Immunotherapies: Real-life Experience for Treatment of Hepatocellular Carcinoma
N/ARecruiting
1,000 participants
Started: Dec 21, 2022 · Completed: Oct 31, 2031
1 condition1 sponsor24 locations
NCT06415981
Proof-of-Concept Study to Determine the Flow Changes When Stimulating Two Neural Targets for the Treatment of Obstructive Sleep Apnea
NAActive, not recruiting
7 participants
Started: Dec 21, 2022 · Completed: Jul 31, 2024
4 conditions2 sponsors1 location
NCT05880914
Precision Medicine Approaches to Renal Osteodystrophy
N/ARecruiting
40 participants
Started: Dec 21, 2022 · Completed: Jun 30, 2027
5 conditions3 sponsors1 location
NCT05161169
Implementation of Whole Genome Sequencing as Screening in a Diverse Cohort of Healthy Infants
NARecruiting
500 participants
Started: Dec 21, 2022 · Completed: Jul 1, 2025
2 conditions13 sponsors4 locations
NCT05743205
Advanced Practice Provider Intervention Study to Promote Wellness
NAActive, not recruiting
300 participants
Started: Dec 21, 2022 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT06389240
Early Weight Bearing in Unicondylar Tibial Plateau Fractures
N/AEnrolling by invitation
60 participants
Started: Dec 21, 2022 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT05813873
The Use of Incentive Spirometry in Adult Patients Hospitalised in a Rehabilitation Center With Long-covid Syndrome
NAActive, not recruiting
70 participants
Started: Dec 21, 2022 · Completed: Dec 31, 2026
1 condition2 sponsors1 location
NCT05675059
Support Through Remote Observation and Nutrition Guidance (STRONG) Program for Pancreatic Cancer Patients
NAActive, not recruiting
80 participants
Started: Dec 21, 2022 · Completed: May 31, 2026
1 condition2 sponsors1 location
NCT06727383
CAR-NK Cells Production and Expansion From Patients With Lympho or Myeloproliferative Disorders and From Healthy Donors
NARecruiting
140 participants
Started: Dec 21, 2022 · Completed: Dec 21, 2025
3 conditions1 sponsor1 location
NCT05525507
Retro-active Immunological Tolerance in Patients With Well-functioning Pre-existing HLA-identical Kidney Transplants
PHASE1Recruiting
10 participants
Started: Dec 21, 2022 · Completed: Sep 30, 2026
4 conditions1 sponsor1 location
NCT05704244
Safety and Efficacy of FE 999326 Administered Intravesically to Japanese Subjects With High-grade, BCG Unresponsive, Non-muscle Invasive Bladder Cancer (NMIBC)
PHASE3Active, not recruiting
25 participants
Started: Dec 21, 2022 · Completed: Nov 30, 2029
1 condition1 sponsor24 locations
NCT05525247
A Phase 1/2, Open-label, Multicenter, Dose Escalation and Expansion Study of SLC-3010 Monotherapy and in Combination
PHASE1/PHASE2Recruiting
420 participants
Started: Dec 21, 2022 · Completed: Jan 31, 2028
1 condition1 sponsor9 locations
NCT05530317
CArdiac REhabilitation for Building Exertional heArt Rate for Chronotropic Incompetence in Long COVID-19
NARecruiting
20 participants
Started: Dec 21, 2022 · Completed: Sep 30, 2025
2 conditions1 sponsor1 location
NCT05711888
Semantic Recognition Task (SRT) in Alzheimer Disease
NARecruiting
80 participants
Started: Dec 21, 2022 · Completed: Dec 26, 2027
1 condition1 sponsor1 location
NCT05681689
PyloPlus Urea Breath Test System Post Therapy Efficacy Confirmation Study
PHASE3Recruiting
77 participants
Started: Dec 21, 2022 · Completed: Jun 30, 2023
3 conditions1 sponsor2 locations
NCT05674825
Investigation of Profile-related Evidence Determining Individualized Cancer Therapy for Patients With Aggressive Malignancies and Poor Prognoses
PHASE1/PHASE2Recruiting
400 participants
Started: Dec 21, 2022 · Completed: Jan 31, 2031
1 condition1 sponsor1 location
NCT05376878
An Investigational Scan (64Cu-DOTA-Trastuzumab PET/MRI) in Imaging Patients With HER2+ Breast Cancer With Brain Metastasis
PHASE4Recruiting
10 participants
Started: Dec 21, 2022 · Completed: Feb 25, 2026
3 conditions2 sponsors1 location
NCT05752552
Study to Determine the Safety and Pharmacokinetics of DO-2 in Patients With Advanced or Refractory Solid Tumours
PHASE1Active, not recruiting
25 participants
Started: Dec 20, 2022 · Completed: Dec 31, 2026
7 conditions1 sponsor8 locations
NCT05653752
A Study of YL202 in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer and Breast Cancer
PHASE1Active, not recruiting
80 participants
Started: Dec 20, 2022 · Completed: Dec 31, 2026
2 conditions2 sponsors13 locations
NCT05190094
Prediction of Treatment Efficacy of the Combination of Palbociclib/(Letrozole or Anastrozole) in First Line Metastatic Women With Luminal, HER2 Negative Advanced Breast Cancer, Using Infrared Laser Spectroscopy Analysis on Liquid Biopsies.
PHASE2Recruiting
80 participants
Started: Dec 20, 2022 · Completed: Jun 30, 2026
1 condition4 sponsors7 locations
NCT05679206
Antiphospholipid Syndrome and Postpartum Pulmonary Artery Pressure
N/ARecruiting
900 participants
Started: Dec 20, 2022 · Completed: Dec 31, 2028
3 conditions1 sponsor1 location
NCT05767216
Genetic and Epigenetic Variations in Heterokaryotypic Monozygotic Twins Discordant for Down Syndrome
NARecruiting
5 participants
Started: Dec 20, 2022 · Completed: Dec 30, 2028
1 condition1 sponsor1 location
NCT05746507
Night Respite for Postpartum Mothers With SUD
NAActive, not recruiting
35 participants
Started: Dec 20, 2022 · Completed: Apr 30, 2025
5 conditions1 sponsor2 locations
NCT05490472
JAB-2485 Activity in Adult Patients With Advanced Solid Tumors
PHASE1/PHASE2Recruiting
102 participants
Started: Dec 20, 2022 · Completed: Aug 31, 2026
5 conditions1 sponsor5 locations
NCT05723718
MalnutritiOn Assessment With biOelectrical impedaNce Analysis in gastRic Cancer patIentS Undergoing Multimodal trEatment
N/ARecruiting
125 participants
Started: Dec 20, 2022 · Completed: Dec 31, 2028
4 conditions5 sponsors1 location
NCT05346627
Home Based Personalized Training and Video Consultation in Mitochondrial Myopathies: Study of Efficacy and Tolerance.
NARecruiting
15 participants
Started: Dec 20, 2022 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT05984875
The Immune Landscape of Epithelial Ovarian Cancer
N/ARecruiting
74 participants
Started: Dec 20, 2022 · Completed: Dec 31, 2026
1 condition2 sponsors1 location
NCT05378399
SmartSteps: A Context-Aware, PrEP Adherence Intervention for Individuals With Substance Use Disorder
PHASE3Recruiting
40 participants
Started: Dec 20, 2022 · Completed: Mar 31, 2026
4 conditions3 sponsors1 location
NCT06211062
The Use of Directed Probiotics in ME/CFS: Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
PHASE2Recruiting
100 participants
Started: Dec 20, 2022 · Completed: Feb 24, 2026
2 conditions1 sponsor1 location
NCT04935684
Faecal Microbiota Transplantation After Allogeneic Stem Cell Transplantation
PHASE2Recruiting
150 participants
Started: Dec 20, 2022 · Completed: Dec 31, 2027
7 conditions3 sponsors20 locations
NCT05532969
Correlation Between Psychological Stress and Progression of Diffuse Astrocytoma Towards Secondary Glioma
N/ANot yet recruiting
60 participants
Started: Dec 20, 2022 · Completed: Dec 20, 2026
1 condition1 sponsor1 location
NCT05536986
Correlation Between Psychological Stress and Progression of Newly Oligodendroglioma Towards Secondary Glioma
N/ANot yet recruiting
60 participants
Started: Dec 20, 2022 · Completed: Dec 20, 2030
1 condition1 sponsor0 locations
NCT05643703
Cesarean Section Defect Mechanism and Transvaginal Repair
NANot yet recruiting
300 participants
Started: Dec 20, 2022 · Completed: Nov 20, 2026
1 condition1 sponsor0 locations
NCT05456412
JAK Inhibition in Ulcerative Colitis
NARecruiting
60 participants
Started: Dec 20, 2022 · Completed: Sep 30, 2026
1 condition2 sponsors1 location
NCT05653453
Clinical Study of Tumor Treating Fields Combined with Gemcitabine and Albumin-bound Paclitaxel in the First-line Treatment of Locally Advanced Pancreatic Cancer
PHASE3Recruiting
512 participants
Started: Dec 20, 2022 · Completed: Sep 28, 2027
1 condition1 sponsor5 locations
NCT05704335
InfluenCEF Study: Study on the Headache Associated With Influenza Infection
N/ARecruiting
100 participants
Started: Dec 20, 2022 · Completed: Nov 30, 2024
5 conditions4 sponsors1 location
NCT05099874
Feasibility and Efficacy of Attentional-Control Training in Sickle Cell Disease
NARecruiting
20 participants
Started: Dec 20, 2022 · Completed: Dec 31, 2025
3 conditions1 sponsor1 location
NCT05657678
Vitamin D3 Supplementation in Critically Ill Patients Undergoing CRRT
PHASE4Recruiting
138 participants
Started: Dec 20, 2022 · Completed: May 1, 2026
1 condition1 sponsor4 locations
NCT05422573
Clinical Trial of the Sequence of Cardiovascular Genetic Counseling and Testing
NAEnrolling by invitation
510 participants
Started: Dec 20, 2022 · Completed: Sep 30, 2026
2 conditions2 sponsors1 location
NCT05683379
AFFINITY BEYOND: Anti-AAV8 Antibody Assessment Study of Boys With DMD
N/ARecruiting
200 participants
Started: Dec 20, 2022 · Completed: Sep 30, 2026
1 condition1 sponsor1 location
NCT05637086
Clinical Study Evaluating Safety of Pentoxifylline and Celecoxib in Patients With Grand-Mal Epilepsy Treated by Phenytoin Monotherapy
PHASE2Recruiting
90 participants
Started: Dec 20, 2022 · Completed: Nov 20, 2027
1 condition3 sponsors1 location
NCT05487599
A Clinical Trial of PR001 (LY3884961) in Patients With Peripheral Manifestations of Gaucher Disease (PROCEED)
PHASE1/PHASE2Recruiting
15 participants
Started: Dec 20, 2022 · Completed: Oct 2, 2030
2 conditions2 sponsors8 locations
NCT06114940
Perioperative TORIPALIMAB Plus LENVATINIB in Patients With Renal Cell Carcinoma Undergoing Nephrectomy (PLUTO)
PHASE2Recruiting
69 participants
Started: Dec 20, 2022 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT05653765
Prognostic Value of the AMR Measured After PPCI in STEMI Patients
N/AActive, not recruiting
2,663 participants
Started: Dec 20, 2022 · Completed: Mar 20, 2025
2 conditions1 sponsor5 locations
NCT05475678
Clinical Study of Camrelizumab Combined With TCb Versus TCb in Neoadjuvant Treatment of Triple-negative Breast Cancer
PHASE2Recruiting
369 participants
Started: Dec 20, 2022 · Completed: Dec 31, 2029
3 conditions1 sponsor1 location
NCT05716997
Relationship Between Coronary Angiography Findings and Fractional Flow Reserve After Balloon Angioplasty
N/ARecruiting
100 participants
Started: Dec 20, 2022 · Completed: Dec 31, 2026
1 condition2 sponsors2 locations
NCT05334784
Impella ECP Study (ECP Study) and Impella ECP Continued Access Protocol
NAEnrolling by invitation
856 participants
Started: Dec 20, 2022 · Completed: Dec 31, 2026
1 condition1 sponsor32 locations
NCT05523596
A Phase 1 Study of the Safety and Tolerability of ICM20 in Adults
PHASE1Active, not recruiting
13 participants
Started: Dec 20, 2022 · Completed: Mar 31, 2027
1 condition1 sponsor3 locations